Amyl Therapeutics (Private limited company)
Amyl Therapeutics is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0758.775.372. It was founded on 26-11-2020. Its registered office is in Liège. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € 3 547 141 and a loss of € 2 015 273. These accounts report 6.8 full-time equivalents. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.
Information last updated on 17-10-2026.
Company information
Key figures of Amyl Therapeutics
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -2 015 273+17 % | € -2 436 601-43 % | € -1 709 641-21 % | € -1 415 300 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 3 547 141-36 % | € 5 562 413-30 % | € 7 999 014+29 % | € 6 208 656 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 7 016 445-16 % | € 8 385 696-6 % | € 8 963 999+34 % | € 6 702 593 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € -365 861+58 % | € -872 434-29 % | € -674 399+20 % | € -840 592 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | 6.8+48 % | 4.6 | - | - |
Financial estimate
- 5 Shareholders
- 4 Board links
Similar companies
Other companies in the same activity in Liège.
| Company | Town |
|---|---|
| Advanced Coatings & Construction Solutions | 4000 Liège |
| Inokura | 4000 Liège |
| ERAL TRADING | 4000 Liège |
| SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE | 4000 Liège |
| MEDIXBEL | 4000 Liège |
| GABRIEL DELEU | 4000 Liège |
| TER-Consult | 4000 Liège |
| BIO-SOURCING | 4000 Liège |
Frequently asked questions
Is Amyl Therapeutics still active? Yes. The Crossroads Bank for Enterprises lists Amyl Therapeutics as active.
What is the VAT number of Amyl Therapeutics? The VAT number of Amyl Therapeutics is BE 0758.775.372.
When was Amyl Therapeutics founded? Amyl Therapeutics was founded on 26-11-2020.
What is the address of Amyl Therapeutics? The current registered office of Amyl Therapeutics is Boulevard de Patience et Beaujonc 3, 4000 Liège.
When did Amyl Therapeutics last file annual accounts? The latest annual accounts of Amyl Therapeutics were filed on 22-07-2026.
Does Amyl Therapeutics file its annual accounts on time? Yes. Amyl Therapeutics filed its annual accounts within the legal deadline for each of its last 4 financial years.
How many employees does Amyl Therapeutics have? Amyl Therapeutics employs 6.8 full-time equivalents according to its most recent annual accounts.
Is Amyl Therapeutics financially healthy? Addrly gives Amyl Therapeutics a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is Amyl Therapeutics profitable? The annual accounts of Amyl Therapeutics for 2025 show a loss of € 2 015 273.
What is the equity of Amyl Therapeutics? The equity of Amyl Therapeutics was € 3 547 141 at the close of the 2025 financial year.
Who are the directors of Amyl Therapeutics? The annual accounts of Amyl Therapeutics record 9 mandates. The names, roles and dates are visible with a free account.
Can Amyl Therapeutics receive Peppol e-invoices? Yes. Amyl Therapeutics is registered on the Peppol network and can receive structured electronic invoices.
What does Amyl Therapeutics do? The main activity of Amyl Therapeutics is: Scientific research and development.